Karen Rossmassler
Concepts (83)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mycobacterium tuberculosis | 9 | 2025 | 314 | 1.460 |
Why?
| | Xylenes | 2 | 2022 | 9 | 1.390 |
Why?
| | Biotransformation | 3 | 2019 | 65 | 1.370 |
Why?
| | Tuberculosis | 8 | 2025 | 279 | 1.190 |
Why?
| | Antitubercular Agents | 8 | 2025 | 206 | 1.070 |
Why?
| | Epsilonproteobacteria | 2 | 2016 | 3 | 0.890 |
Why?
| | Metagenomics | 3 | 2019 | 169 | 0.680 |
Why?
| | Microbial Consortia | 1 | 2019 | 18 | 0.610 |
Why?
| | Enzymes | 1 | 2019 | 67 | 0.600 |
Why?
| | Sulfur | 2 | 2016 | 58 | 0.590 |
Why?
| | Genetic Markers | 1 | 2019 | 344 | 0.570 |
Why?
| | Carbon | 1 | 2019 | 216 | 0.550 |
Why?
| | Diarylquinolines | 3 | 2025 | 16 | 0.520 |
Why?
| | Gammaproteobacteria | 1 | 2016 | 13 | 0.510 |
Why?
| | Hot Springs | 1 | 2016 | 9 | 0.510 |
Why?
| | Isoptera | 1 | 2015 | 5 | 0.500 |
Why?
| | Biodegradation, Environmental | 3 | 2022 | 84 | 0.480 |
Why?
| | Metabolic Networks and Pathways | 1 | 2016 | 180 | 0.470 |
Why?
| | Linezolid | 2 | 2025 | 23 | 0.460 |
Why?
| | Metagenome | 1 | 2015 | 147 | 0.460 |
Why?
| | Caves | 1 | 2011 | 4 | 0.380 |
Why?
| | Fresh Water | 1 | 2011 | 57 | 0.360 |
Why?
| | Microbiota | 1 | 2019 | 762 | 0.350 |
Why?
| | Mice, Inbred BALB C | 5 | 2025 | 1272 | 0.340 |
Why?
| | Anaerobiosis | 2 | 2022 | 64 | 0.340 |
Why?
| | RNA, Ribosomal | 2 | 2021 | 168 | 0.340 |
Why?
| | Gastrointestinal Microbiome | 1 | 2015 | 697 | 0.280 |
Why?
| | Bacteria | 3 | 2017 | 858 | 0.240 |
Why?
| | Polymerase Chain Reaction | 2 | 2022 | 1062 | 0.220 |
Why?
| | Tuberculosis, Pulmonary | 2 | 2024 | 141 | 0.220 |
Why?
| | RNA, Bacterial | 2 | 2021 | 190 | 0.210 |
Why?
| | RNA, Ribosomal, 16S | 2 | 2016 | 549 | 0.210 |
Why?
| | Disease Models, Animal | 5 | 2025 | 4295 | 0.200 |
Why?
| | DNA, Complementary | 1 | 2022 | 272 | 0.180 |
Why?
| | Drug Therapy, Combination | 4 | 2025 | 1066 | 0.170 |
Why?
| | Phylogeny | 2 | 2016 | 904 | 0.160 |
Why?
| | Anti-Infective Agents | 1 | 2023 | 255 | 0.160 |
Why?
| | RNA Precursors | 1 | 2021 | 154 | 0.160 |
Why?
| | Sputum | 1 | 2021 | 311 | 0.160 |
Why?
| | Microbial Sensitivity Tests | 3 | 2025 | 361 | 0.150 |
Why?
| | Thiothrix | 1 | 2016 | 1 | 0.130 |
Why?
| | Water Microbiology | 1 | 2016 | 85 | 0.120 |
Why?
| | Sulfides | 1 | 2016 | 99 | 0.120 |
Why?
| | Genes, Bacterial | 1 | 2015 | 164 | 0.120 |
Why?
| | Pharmaceutical Preparations | 1 | 2017 | 179 | 0.120 |
Why?
| | Nitroimidazoles | 2 | 2025 | 13 | 0.120 |
Why?
| | Anti-Bacterial Agents | 1 | 2025 | 1809 | 0.110 |
Why?
| | Water Pollutants, Chemical | 1 | 2017 | 215 | 0.110 |
Why?
| | Mice | 7 | 2025 | 17787 | 0.110 |
Why?
| | Animals | 8 | 2025 | 36940 | 0.100 |
Why?
| | Oxidation-Reduction | 1 | 2016 | 1060 | 0.100 |
Why?
| | Hydrothermal Vents | 1 | 2011 | 2 | 0.090 |
Why?
| | RNA, Ribosomal, 23S | 1 | 2011 | 14 | 0.090 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2015 | 539 | 0.090 |
Why?
| | Genes, rRNA | 1 | 2011 | 41 | 0.090 |
Why?
| | Base Sequence | 1 | 2011 | 2181 | 0.070 |
Why?
| | Transcriptome | 2 | 2025 | 971 | 0.070 |
Why?
| | Molecular Sequence Data | 1 | 2011 | 2900 | 0.070 |
Why?
| | Lung | 3 | 2024 | 4060 | 0.060 |
Why?
| | Pyrazinamide | 1 | 2025 | 12 | 0.060 |
Why?
| | Streptomycin | 1 | 2025 | 18 | 0.060 |
Why?
| | Ethambutol | 1 | 2025 | 26 | 0.060 |
Why?
| | Isoniazid | 1 | 2025 | 63 | 0.060 |
Why?
| | Rifampin | 1 | 2025 | 84 | 0.060 |
Why?
| | Drug Interactions | 1 | 2025 | 410 | 0.050 |
Why?
| | Mice, Inbred C3H | 1 | 2023 | 269 | 0.050 |
Why?
| | Mice, Inbred Strains | 1 | 2023 | 409 | 0.050 |
Why?
| | Female | 6 | 2025 | 73304 | 0.050 |
Why?
| | Benchmarking | 1 | 2023 | 186 | 0.040 |
Why?
| | Gene Expression Regulation, Bacterial | 1 | 2023 | 328 | 0.040 |
Why?
| | Adaptation, Physiological | 1 | 2023 | 553 | 0.040 |
Why?
| | United States | 1 | 2016 | 14841 | 0.040 |
Why?
| | Transcription, Genetic | 1 | 2023 | 1457 | 0.030 |
Why?
| | Groundwater | 1 | 2017 | 40 | 0.030 |
Why?
| | Gene Expression Profiling | 1 | 2023 | 1774 | 0.030 |
Why?
| | Phenotype | 1 | 2025 | 3196 | 0.030 |
Why?
| | Water Purification | 1 | 2017 | 152 | 0.030 |
Why?
| | Humans | 5 | 2023 | 137585 | 0.030 |
Why?
| | Mice, Inbred C57BL | 1 | 2023 | 5757 | 0.020 |
Why?
| | Biomarkers | 1 | 2021 | 4149 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2021 | 10811 | 0.020 |
Why?
| | Adult | 1 | 2021 | 37929 | 0.010 |
Why?
| | Male | 1 | 2021 | 67762 | 0.010 |
Why?
|
|
Rossmassler's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|